Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Women With Breast Cancer 1Heart Failure 1Colorectal Neoplasms 1Childhood Cancer Survivors 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Perindopril × Clear all
NCT04588935 2023-02-08

Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

State Institution "Republican Scientific and Practical Center" Cardiology, Belarus

Phase 2 Completed
100 enrolled
Breast

Women With Breast Cancer

NCT02651415 2019-09-12

PARICCA

British Columbia Cancer Agency

Phase 2 Completed
12 enrolled 13 charts
Gastrointestinal

Colorectal Neoplasms

NCT01016886 2016-02-09

MANTICORE

AHS Cancer Control Alberta

Phase 1/2 Unknown
99 enrolled
Breast

Breast Neoplasms, Heart Failure, Cardiotoxicity

NCT01948232 2015-10-06

Pilot Study of Perindopril in Childhood Cancer Survivors

The Hospital for Sick Children

Phase 2 Withdrawn

Childhood Cancer Survivors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡